Overexpression of B7H5/CD28H is associated with worse survival in human gastric cancer

Gastric cancer (GC) is a common malignancy with low 5‐year overall survival (OS). Recently, immune therapy has been used to treat cancer. B7H5 and CD28H are novel immune checkpoint molecules. However, the prognostic value of B7H5/CD28H expression in patients with GC remains unclear. In this study, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Can, Xu, Zhiyuan, Chen, Shangqi, Lv, Hang, Wang, Yiping, Wang, Xiaofeng, Mo, Shaowei, Shi, Chengwei, Wei, Shenyu, Hu, Liqiang, Chen, Wei, Cheng, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991633/
https://www.ncbi.nlm.nih.gov/pubmed/31883303
http://dx.doi.org/10.1111/jcmm.14812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991633/
https://www.ncbi.nlm.nih.gov/pubmed/31883303
http://dx.doi.org/10.1111/jcmm.14812

Ejemplares similares